Katalyze AI has appointed scientist and technologist Hannes Bretschneider as Chief AI Officer, strengthening the company’s leadership as it advances agentic AI for life-science manufacturing. Bretschneider, a co-founder of Deep Genomics, brings extensive experience in machine learning, genomics, RNA biology, and regulated computational systems.
His past work includes developing GenomeKit, pioneering splicing-prediction models, and leading machine-learning collaborations at the University of Toronto and Fable Therapeutics. CEO Reza Farahani said his expertise enhances Katalyze AI’s efforts to build autonomous agents capable of real-time decision-making in pharmaceutical production. A phased rollout of new agentic tools is planned.
Want to know more? Check out the source code here.